Tirzepatide is a dual GIP and GLP-1 receptor agonist — a “twincretin” that is among the most-studied metabolic research peptides for its combined incretin action.
What is tirzepatide?
Tirzepatide (development code LY3298176) is a synthetic peptide studied as a dual agonist of two incretin receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Because it engages both, it is often called a “twincretin.” It is a 39-amino-acid peptide modified with a C20 fatty-diacid chain that promotes albumin binding and a long duration of action.
How the dual-incretin mechanism is studied
GLP-1 and GIP are both incretin hormones — released after nutrient intake and involved in insulin signaling. Research on tirzepatide focuses on what happens when a single molecule activates both receptor systems at once. Reported research directions include:
- Glucose-dependent insulin signaling in metabolic models.
- Glucagon regulation and gastric-emptying pathways.
- Appetite and energy-balance research via central incretin signaling.
- Body-composition models.
Half-life & forms
Tirzepatide has a long research half-life of roughly five days, which is why study protocols typically use once-weekly schedules. It is supplied as a lyophilized powder for reconstitution.
Tirzepatide vs semaglutide
The most common comparison is with semaglutide, a single GLP-1 agonist. The key structural difference is receptor coverage — tirzepatide adds GIP-receptor activity. See the full tirzepatide vs semaglutide comparison, and the newer triple agonist retatrutide in retatrutide vs tirzepatide.
Reconstitution, handling & storage
Tirzepatide ships lyophilized and is reconstituted with bacteriostatic water, then refrigerated. Use the reconstitution calculator for exact volumes and the storage guide for stability. For the category, see GLP-1 & metabolic peptides.
Frequently asked questions
What is tirzepatide?
Tirzepatide (LY3298176) is a synthetic peptide studied as a dual GIP and GLP-1 receptor agonist — a "twincretin" — in metabolic and appetite-regulation research.
How is tirzepatide different from semaglutide?
Semaglutide activates the GLP-1 receptor only; tirzepatide activates both GIP and GLP-1 receptors. See our tirzepatide vs semaglutide comparison for detail.
What is the half-life of tirzepatide?
In research models tirzepatide has a half-life of roughly five days, which is why study protocols typically use once-weekly schedules.
How is tirzepatide reconstituted?
It ships as a lyophilized powder and is reconstituted with bacteriostatic water, then refrigerated. Our calculator gives exact volumes for your target concentration.
Is tirzepatide lab-tested?
Yes — every lot is lab-tested to a 99%+ purity standard with a batch-specific COA available on request.
Why researchers order from Miami Peptide Lab
- 99%+ purity, lab-tested every lot — a batch-specific COA is available on request.
- Ships from Miami and across the US in 24–48 business hours with tracking, in discreet cold-chain packaging.
- Buy-more-save-more bundle pricing on every vial, plus a reship-or-refund guarantee.
Research use only
All products referenced here are sold strictly for laboratory and research use. They are not intended for human or animal consumption, nor for any therapeutic, diagnostic, or cosmetic use, and must be handled only by qualified professionals in an appropriate research setting.
